NCT07324967 A Standardized Counseling Approach to Preoperative Education in Transmasculine Individuals Receiving Gender-affirming Surgery
| NCT ID | NCT07324967 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Minnesota |
| Condition | Hysterectomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2026-03-12 |
| Primary Completion | 2028-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2026-03-12 with a primary completion date of 2028-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The intervention will be an educational handout provided to a randomized cohort of patients that reviews the benefits and risks of retaining ovaries vs removing them. This educational handout will be provided prior to the surgical consultation at the time of the initial survey.
Eligibility Criteria
Inclusion Criteria: * Any transgender or non-binary individual * Age 18-65 * Assigned female at birth who desires a gender-affirming hysterectomy with or without oophorectomy * English-speaking Exclusion Criteria: * Non-transgender individuals * Any transgender individual who has already had a bilateral oophorectomy * Any transgender person who was born without ovaries or a uterus * Non-English speaking
Contact & Investigator
Andrea Johnson
PRINCIPAL INVESTIGATOR
University of Minnesota
Frequently Asked Questions
Who can join the NCT07324967 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Hysterectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07324967 currently recruiting?
Yes, NCT07324967 is actively recruiting participants. Contact the research team at obgynresearch@umn.edu for enrollment information.
Where is the NCT07324967 trial being conducted?
This trial is being conducted at Minneapolis, United States.
Who is sponsoring the NCT07324967 clinical trial?
NCT07324967 is sponsored by University of Minnesota. The principal investigator is Andrea Johnson at University of Minnesota. The trial plans to enroll 250 participants.